Cohort Study: Incretin Based Drugs and Risk of Cholangiocarcinoma Among Patients with Type 2 Diabetes
13 Dec, 2018 | 19:47h | UTCCommentary: Do incretin-based drugs cause cholangiocarcinoma? – Univadis (free registration required)
Commentary: Do incretin-based drugs cause cholangiocarcinoma? – Univadis (free registration required)